1. Home
  2. LYRA vs AMST Comparison

LYRA vs AMST Comparison

Compare LYRA & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • AMST
  • Stock Information
  • Founded
  • LYRA 2005
  • AMST 2017
  • Country
  • LYRA United States
  • AMST United States
  • Employees
  • LYRA N/A
  • AMST N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • AMST Computer Software: Prepackaged Software
  • Sector
  • LYRA Health Care
  • AMST Technology
  • Exchange
  • LYRA Nasdaq
  • AMST Nasdaq
  • Market Cap
  • LYRA 11.3M
  • AMST 13.3M
  • IPO Year
  • LYRA 2020
  • AMST 2020
  • Fundamental
  • Price
  • LYRA $6.41
  • AMST $3.14
  • Analyst Decision
  • LYRA Hold
  • AMST
  • Analyst Count
  • LYRA 1
  • AMST 0
  • Target Price
  • LYRA $16.00
  • AMST N/A
  • AVG Volume (30 Days)
  • LYRA 14.8K
  • AMST 2.1M
  • Earning Date
  • LYRA 11-11-2025
  • AMST 11-13-2025
  • Dividend Yield
  • LYRA N/A
  • AMST N/A
  • EPS Growth
  • LYRA N/A
  • AMST N/A
  • EPS
  • LYRA N/A
  • AMST N/A
  • Revenue
  • LYRA $770,000.00
  • AMST $82,544.00
  • Revenue This Year
  • LYRA N/A
  • AMST N/A
  • Revenue Next Year
  • LYRA $123.46
  • AMST N/A
  • P/E Ratio
  • LYRA N/A
  • AMST N/A
  • Revenue Growth
  • LYRA N/A
  • AMST N/A
  • 52 Week Low
  • LYRA $3.81
  • AMST $2.00
  • 52 Week High
  • LYRA $37.50
  • AMST $6.27
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 38.58
  • AMST 53.57
  • Support Level
  • LYRA $6.15
  • AMST $3.14
  • Resistance Level
  • LYRA $6.72
  • AMST $3.56
  • Average True Range (ATR)
  • LYRA 0.38
  • AMST 0.29
  • MACD
  • LYRA -0.01
  • AMST 0.08
  • Stochastic Oscillator
  • LYRA 25.85
  • AMST 24.77

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About AMST Amesite Inc.

Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.

Share on Social Networks: